Nail Psoriasis (Q22305813)

Dimensions

7 February 2023

Wei-Sheng Chong

series ordinal

2

author given names

Wei-Sheng

author last names

Chong

1 reference

Dimensions

7 February 2023

Hong Liang Tey

series ordinal

3

author given names

Hong Liang

author last names

Tey

1 reference

Dimensions

American Journal of Clinical Dermatology

7 February 2023

language of work or name

English

0 references

publication date

December 2012

0 references

published in

1 reference

https://scigraph.springernature.com/pub.10.2165/11597000-000000000-00000

PubMed

volume

13

0 references

issue

6

0 references

page(s)

375-388

0 references

exact match

0 references

cites work

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

A review of the epidemiology of psoriasis vulgaris in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Trends in incidence of adult-onset psoriasis over three decades: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Developments in the treatment of nail psoriasis, melanonychia striata, and onychomycosis. A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Nail psoriasis in Germany: epidemiology and burden of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Psoriasis and psoriatic arthritis: clinical features and disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Management of nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Nail psoriasis: clinical presentation and best practice recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Clinical pathologic correlations for diagnosis and treatment of nail disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Modification of the Nail Psoriasis Severity Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Development and validation of nail psoriasis quality of life scale (NPQ10).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Calcipotriol ointment. A review of its use in the management of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Molecular mechanisms of tazarotene action in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Receptor-selective retinoids for psoriasis: focus on tazarotene

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Instability of topical ciclosporin emulsion for nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Innovative use of topical calcineurin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Management of psoriatic nail disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Efficacy of triamcinolone acetonide in various acquired nail dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

A simplified protocol of steroid injection for psoriatic nail dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

In vivo quantification of the structural abnormalities in psoriatic microvessels before and after pulsed dye laser treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Pulsed dye laser in the treatment of nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

An impressive therapeutic result of nail psoriasis to acitretin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Severe nail psoriasis with a rapid response to acitretin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Evaluation of the efficacy of acitretin therapy for nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Pustular psoriasis of the nails: treatment and long-term follow-up of 46 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Treatment of nail psoriasis with adalimumab: an open label unblinded study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Biological therapy and nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Development and use of alefacept to treat psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Therapeutic effects of a 12-week course of alefacept on nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Ustekinumab for the treatment of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: Are they the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

Response of psoriatic nails to oral photochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Distal phalangeal atrophy secondary to topical steroid therapy

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

UV-A and UV-B penetration of normal human cadaveric fingernail plate

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Idiopathic splinter hemorrhages

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Alefacept in the treatment of psoriatic nail disease: a small case series

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Corticosteroid-induced 'disappearing digit'

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Topical anthralin therapy for refractory nail psoriasis

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Local PUVA treatment for nail psoriasis.

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Topical ciclosporin in nail psoriasis

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Etanercept: an overview of its role in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

Treatment of severe nail psoriasis with etanercept

1 reference

https://api.crossref.org/works/10.2165%2F11597000-000000000-00000

7 January 2021

10.2165/11597000-000000000-00000

Identifiers

DOI

0 references